import { EducationalContent } from '../../types';

export const pacemakerImplant: EducationalContent = {
  id: 'pacemakerimplant',
  type: 'concept',
  name: 'Pacemaker Implantation',
  nameEs: 'Implante de Marcapasos',
  levels: {
    1: {
      level: 1,
      summary: 'A pacemaker is a small electronic device implanted under the skin that sends electrical signals to the heart to maintain a regular heartbeat when the heart\'s natural rhythm is too slow or irregular.',
      explanation: 'A pacemaker is a small battery-powered device about the size of a large coin that is placed under the skin, usually just below the collarbone. It helps control abnormal heart rhythms by sending tiny electrical pulses to the heart muscle to keep it beating at a normal rate.\n\nThe heart has its own natural pacemaker called the sinoatrial (SA) node, a small cluster of specialized cells in the upper right chamber that generates electrical signals to trigger each heartbeat. These signals travel through the heart in an organized pattern, causing the chambers to contract in the proper sequence. When this natural electrical system malfunctions, the heart may beat too slowly (a condition called bradycardia), causing symptoms such as dizziness, fatigue, fainting, and shortness of breath.\n\nA pacemaker system has two main components. The pulse generator is the metal case containing the battery and electronic circuits that generate the electrical pulses. It is usually implanted in a small pocket under the skin below the collarbone. The leads (wires) are thin, insulated wires that connect the pulse generator to the heart. These leads carry the electrical pulses from the device to the heart and also sense the heart\'s natural electrical activity.\n\nThere are different types of pacemakers depending on how many leads are used. A single-chamber pacemaker has one lead placed in either the right atrium or the right ventricle. A dual-chamber pacemaker has two leads, one in the right atrium and one in the right ventricle, allowing it to coordinate the timing between the upper and lower chambers. A biventricular pacemaker (also called cardiac resynchronization therapy or CRT) has three leads and is used to help both lower chambers of the heart beat together in a synchronized pattern.\n\nPacemaker implantation is performed under local anesthesia with conscious sedation. A small incision is made below the collarbone, and the leads are threaded through a vein into the heart under X-ray guidance. The procedure typically takes 1-2 hours, and most patients go home the same day or the next morning. After implantation, patients will have regular follow-up appointments to check the pacemaker function, which can now often be done remotely through wireless monitoring from home.\n\nModern pacemakers are very reliable and their batteries typically last 8-15 years. When the battery runs low, the pulse generator is replaced in a simple procedure, and the original leads are usually kept in place.',
      keyTerms: [
        { term: 'Pacemaker', definition: 'A small electronic device implanted under the skin that sends electrical pulses to the heart to maintain a regular heartbeat' },
        { term: 'Bradycardia', definition: 'An abnormally slow heart rate, typically below 60 beats per minute, that may cause symptoms when the heart cannot pump enough blood' },
        { term: 'Pulse generator', definition: 'The metal case of a pacemaker containing the battery and electronic circuits that create the electrical signals' },
        { term: 'Leads', definition: 'Thin insulated wires that connect the pacemaker to the heart, delivering electrical pulses and sensing heart activity' },
        { term: 'Dual-chamber pacemaker', definition: 'A pacemaker with leads in both the right atrium and right ventricle that coordinates timing between the upper and lower chambers' }
      ],
      clinicalNotes: 'Common indications for pacemaker implantation include symptomatic sinus node dysfunction, complete (third-degree) heart block, and symptomatic second-degree heart block. After implantation, patients should avoid raising the arm on the implant side above shoulder level for 4-6 weeks to prevent lead dislodgement. Patients should be given a pacemaker identification card and counseled about MRI compatibility (most modern devices are MRI-conditional), avoiding strong magnetic fields, and notifying healthcare providers about the device before any medical procedures.'
    },
    2: {
      level: 2,
      summary: 'Pacemaker implantation addresses symptomatic bradyarrhythmias through transvenous lead placement and pulse generator implantation, with device selection (single-chamber, dual-chamber, CRT) determined by the underlying conduction abnormality and clinical indication.',
      explanation: 'Pacemaker implantation is a standard procedure for the management of symptomatic bradyarrhythmias and specific conduction system disorders. Understanding the cardiac conduction system and its pathology is essential for appropriate device selection and programming.\n\nThe cardiac conduction system consists of the sinoatrial (SA) node (the heart\'s primary pacemaker, generating impulses at 60-100 beats per minute), the atrioventricular (AV) node (which delays impulse transmission between atria and ventricles), the bundle of His, the right and left bundle branches, and the Purkinje fibers. Disease at any level can produce bradycardia requiring pacemaker therapy.\n\nSinus node dysfunction (SND, previously called sick sinus syndrome) includes sinus bradycardia, sinus pauses or arrest, sinoatrial exit block, and tachy-brady syndrome (alternating tachycardia and bradycardia). SND is the most common indication for pacemaker implantation, accounting for approximately 50% of implants. An atrial-based pacing mode (AAI or DDD) is preferred to maintain AV synchrony.\n\nAV block is classified by degree. First-degree AV block (PR interval greater than 200 ms) rarely requires pacing. Second-degree AV block includes Mobitz Type I (Wenckebach, progressive PR prolongation before a dropped beat, usually at the AV node, often benign) and Mobitz Type II (sudden dropped beats without PR prolongation, usually below the AV node, higher risk of progression to complete block). Third-degree (complete) AV block is a complete absence of AV conduction with an escape rhythm originating below the block. Mobitz Type II and complete heart block generally require pacemaker implantation.\n\nThe pacemaker code uses a standardized five-letter system. The first letter indicates the chamber paced (A=atrium, V=ventricle, D=dual), the second indicates the chamber sensed, the third indicates the response to sensing (I=inhibited, T=triggered, D=dual), the fourth indicates rate-responsive capability (R=rate responsive), and the fifth indicates multisite pacing. Common modes include VVI (ventricular pacing and sensing, inhibited by sensed events), DDD (dual-chamber pacing and sensing with dual response), and DDDR (DDD with rate response).\n\nThe implantation procedure begins with venous access, typically via the cephalic vein (preferred due to lower complication rates) or subclavian vein. Leads are advanced under fluoroscopic guidance to the right atrial appendage (atrial lead) and right ventricular apex or septum (ventricular lead). Lead position is confirmed by fluoroscopy and electrophysiologic testing including measurement of sensing amplitude (intracardiac electrogram amplitude), pacing threshold (minimum output that captures the myocardium), and impedance (resistance, typically 400-1200 ohms). Acceptable thresholds are less than 1.0 volt at 0.5 ms pulse width for both atrial and ventricular leads. The pulse generator is then connected to the leads and placed in a subcutaneous or subpectoral pocket.\n\nCardiac resynchronization therapy (CRT) adds a left ventricular lead placed through the coronary sinus into a lateral or posterolateral cardiac vein. CRT is indicated for patients with heart failure (LVEF less than or equal to 35%), New York Heart Association class II-IV symptoms on guideline-directed medical therapy, and QRS duration greater than or equal to 150 ms with left bundle branch block morphology. The COMPANION and MADIT-CRT trials demonstrated improved symptoms, reduced hospitalizations, and improved survival with CRT.\n\nComplications of pacemaker implantation include pneumothorax (1-2% with subclavian approach, less with cephalic), lead dislodgement (2-3% in the first 6 weeks), infection (1-2%), hematoma at the pocket site, cardiac perforation (rare), and pacemaker syndrome (symptoms from loss of AV synchrony, typically with VVI pacing).',
      keyTerms: [
        { term: 'Sinus node dysfunction', definition: 'A group of arrhythmias caused by abnormal impulse generation or conduction from the SA node, including sinus bradycardia, sinus pauses, and tachy-brady syndrome' },
        { term: 'AV block', definition: 'Impaired or absent conduction of electrical impulses from the atria to the ventricles, classified as first, second (Type I or II), or third degree' },
        { term: 'Pacemaker code', definition: 'A standardized five-letter system describing pacemaker function: chambers paced, chambers sensed, response to sensing, rate responsiveness, and multisite pacing' },
        { term: 'Pacing threshold', definition: 'The minimum electrical output required to consistently depolarize (capture) the myocardium through the pacemaker lead' },
        { term: 'Cardiac resynchronization therapy (CRT)', definition: 'Biventricular pacing that coordinates contraction of both ventricles to improve cardiac efficiency in heart failure patients with electrical dyssynchrony' },
        { term: 'Pacemaker syndrome', definition: 'Symptoms (fatigue, dizziness, hypotension) resulting from loss of AV synchrony during ventricular-only pacing, caused by atrial contraction against closed AV valves' }
      ],
      clinicalNotes: 'Mode selection is critical: avoid VVI pacing in patients with intact sinus node function due to pacemaker syndrome risk; DDD or DDDR is preferred. The cephalic vein cutdown approach reduces pneumothorax risk compared to subclavian puncture. Post-implant chest X-ray should be obtained to confirm lead positions and rule out pneumothorax. First follow-up should occur within 2 weeks of implantation, with subsequent checks at 3 months, then every 6-12 months. Remote monitoring reduces in-person visits while maintaining safety and should be offered to all patients.'
    },
    3: {
      level: 3,
      summary: 'Advanced pacemaker management includes optimal lead positioning strategies, His-bundle and left bundle branch area pacing, management of device-related complications, pacemaker-mediated tachycardia troubleshooting, and MRI-conditional device considerations.',
      explanation: 'Advanced pacemaker practice requires expertise in lead positioning techniques, programming optimization, complication management, and emerging conduction system pacing modalities that aim to preserve physiologic ventricular activation.\n\nLead positioning strategies have evolved significantly. Traditional right ventricular apical (RVA) pacing, while technically straightforward, produces a non-physiologic activation pattern similar to left bundle branch block that can cause ventricular dyssynchrony. Long-term RVA pacing with high pacing burden (greater than 40%) is associated with pacing-induced cardiomyopathy and heart failure. Alternative RV lead positions include the RV septum (mid-septal or high-septal positions), which may produce a narrower paced QRS complex and more physiologic activation, although randomized trials have not consistently demonstrated superiority over apical pacing for clinical outcomes.\n\nHis-bundle pacing (HBP) delivers pacing stimuli directly to the His bundle, producing physiologic ventricular activation through the native His-Purkinje system. HBP can correct bundle branch blocks in many patients, including left bundle branch block, by recruiting longitudinal fibers within the His bundle distal to the site of conduction block. Selective His capture produces a narrow QRS identical to intrinsic conduction, while non-selective His capture produces a slightly wider QRS due to local myocardial capture combined with His-Purkinje activation. Challenges of HBP include higher pacing thresholds, lower sensing amplitudes, longer implant times, and concern for long-term threshold stability.\n\nLeft bundle branch area pacing (LBBAP) is a newer conduction system pacing technique where the lead is screwed through the interventricular septum from the RV side to capture the left bundle branch or its fascicles. LBBAP produces a right bundle branch block-like paced morphology with rapid left ventricular activation. Advantages over HBP include lower thresholds, higher sensing amplitudes, and more stable long-term parameters. The left bundle branch pacing area is larger than the His bundle, providing a broader target and higher success rate. LBBAP is emerging as the preferred conduction system pacing technique in many centers.\n\nPacemaker-mediated tachycardia (PMT) is a reentrant tachycardia in dual-chamber pacemakers where a retrograde P wave conducted through the AV node or accessory pathway is sensed by the atrial lead, triggering ventricular pacing, which in turn generates another retrograde P wave. PMT is prevented by programming the post-ventricular atrial refractory period (PVARP) long enough to prevent sensing of retrograde atrial activation. Most modern devices have automatic PMT detection and termination algorithms.\n\nPacemaker-related complications requiring management include:\n\nLead failure: Conductor fracture or insulation break causing intermittent or complete failure of pacing or sensing. Diagnosis requires impedance monitoring (high impedance suggests conductor fracture, low impedance suggests insulation break) and fluoroscopic evaluation for visible lead damage. Management involves lead revision or extraction and new lead implantation.\n\nDevice infection: Pocket infection presents with erythema, warmth, and drainage at the generator site. Lead endocarditis (infection on the intravascular leads) is a more serious condition requiring complete device and lead extraction, prolonged antibiotics, and reimplantation at a different site after infection clearance. TEE should be performed to assess for lead vegetations.\n\nLead extraction: Performed using specialized sheaths (mechanical or laser) that dissect fibrotic adhesions along the lead. Lead extraction carries risks of vascular tear, cardiac perforation, and tamponade and should be performed at experienced centers with cardiac surgical backup.\n\nMRI-conditional pacemakers have become standard, allowing patients to undergo MRI examinations under specific conditions. Requirements typically include an MRI-conditional generator paired with MRI-conditional leads (both from the same manufacturer), no abandoned leads, no lead extenders or adaptors, and specific programming changes before and after the scan. The programming protocol includes switching to asynchronous mode (DOO or VOO) for pacing-dependent patients or inhibited mode (ODO or OVO) for non-dependent patients, disabling rate response and other algorithms, and verifying lead parameters before and after the scan.',
      keyTerms: [
        { term: 'His-bundle pacing', definition: 'A physiologic pacing technique delivering stimuli directly to the His bundle, activating the ventricles through the native His-Purkinje conduction system' },
        { term: 'Left bundle branch area pacing (LBBAP)', definition: 'A conduction system pacing technique where the lead is advanced through the RV septum to capture the left bundle branch, producing rapid physiologic left ventricular activation' },
        { term: 'Pacemaker-mediated tachycardia', definition: 'A reentrant tachycardia in dual-chamber pacemakers involving retrograde VA conduction sensed by the atrial lead, creating a continuous pacing loop at the upper tracking rate' },
        { term: 'Lead extraction', definition: 'A specialized procedure to remove chronically implanted pacemaker leads using mechanical or laser sheaths to dissect surrounding fibrotic tissue' },
        { term: 'Pacing-induced cardiomyopathy', definition: 'Decline in left ventricular function caused by chronic non-physiologic ventricular pacing (typically RV apical), occurring in patients with high pacing burden' },
        { term: 'MRI-conditional device', definition: 'A pacemaker system (generator and leads) tested and approved for safe use during MRI under specific conditions including programming modifications and scan parameter limitations' }
      ],
      clinicalNotes: 'Consider conduction system pacing (His bundle or LBBAP) for patients expected to have high ventricular pacing burden (greater than 40%), particularly those with preserved LVEF where pacing-induced cardiomyopathy would be detrimental. LBBAP has a steeper learning curve but more reliable long-term parameters than HBP. For device infection, the entire system (generator and all leads) must be extracted; antibiotic-only treatment without extraction has unacceptably high relapse rates (greater than 50%). Before MRI, verify the device is truly MRI-conditional (check manufacturer labeling) and follow the specific conditions of use exactly. Do not scan patients with abandoned leads or non-conditional components.'
    },
    4: {
      level: 4,
      summary: 'Advanced pacemaker topics include leadless pacemaker technology, conduction system pacing for CRT, adaptive pacing algorithms, management of complex device interactions, and optimization strategies for special populations including pediatric and congenital heart disease patients.',
      explanation: 'Expert-level pacemaker practice encompasses emerging device technologies, sophisticated programming strategies, and management of complex clinical scenarios requiring integration of electrophysiology, heart failure, and device expertise.\n\nLeadless pacemakers represent a paradigm shift in cardiac pacing. The Medtronic Micra transcatheter pacing system is a self-contained device (approximately the size of a large vitamin capsule) that is delivered through the femoral vein and implanted directly in the right ventricle using tine-based fixation. The Micra eliminates the need for a subcutaneous pocket and transvenous leads, avoiding lead-related complications (fracture, dislodgement, infection) and pocket-related complications (hematoma, erosion). The original Micra provided single-chamber VVI pacing, but the newer Micra AV uses an accelerometer to detect atrial mechanical contraction and provides AV synchronous ventricular pacing without an atrial lead. The Abbott AZIA leadless pacemaker system is designed for dual-chamber leadless pacing using communicating atrial and ventricular devices.\n\nConduction system pacing as an alternative to CRT (CSP-CRT) is an active area of investigation. For patients with heart failure, LBBB, and CRT indication, left bundle branch area pacing may achieve cardiac resynchronization by correcting the LBBB through physiologic conduction system recruitment, avoiding the need for a coronary sinus lead (which has a 5-10% failure rate of placement). Early studies (LOT-CRT, LBBP-RESYNC) demonstrate comparable or superior echocardiographic response and clinical outcomes with LBBAP-CRT compared to conventional biventricular CRT. His-bundle pacing for CRT has been investigated in the His-SYNC and His-alternative trials with promising results, though higher thresholds and lead instability remain concerns.\n\nAdaptive pacing algorithms represent sophisticated programming features that automatically adjust device behavior based on patient physiology. Managed Ventricular Pacing (MVP, Medtronic) operates in AAI mode with automatic mode switching to DDD when AV block is detected, minimizing unnecessary ventricular pacing. Rate-drop response provides temporary higher-rate pacing when a sudden drop in heart rate is detected, useful for vasovagal syncope. Closed-loop stimulation (CLS, Biotronik) uses right ventricular impedance changes reflecting myocardial contractility dynamics to modulate pacing rate based on autonomic nervous system activity rather than motion sensors, providing more physiologic rate adaptation during emotional stress and postural changes.\n\nPediatric pacemaker implantation presents unique challenges including small patient size (requiring epicardial lead placement via thoracotomy in neonates and small children), rapid somatic growth (necessitating lead redundancy to accommodate growth), limited venous access options, and the need for MRI-conditional systems for lifetime imaging needs. Epicardial steroid-eluting leads have improved long-term thresholds in pediatric patients. In adolescents large enough for transvenous systems, lead selection should prioritize long-term reliability given decades of anticipated pacing.\n\nPacing in congenital heart disease requires specialized expertise due to altered cardiac anatomy. Post-surgical complete heart block (after VSD repair, tetralogy of Fallot repair, or AV canal repair) is a common indication. Patients with single-ventricle physiology (Fontan circulation), transposition of the great arteries (after atrial switch or arterial switch operations), and congenitally corrected transposition present complex access challenges. In Fontan patients, epicardial pacing is often required due to absence of direct venous access to the ventricle. In patients with transvenous systemic venous baffles, lead placement requires navigation through complex surgically altered anatomy.\n\nDevice-device interactions in patients with multiple implanted electronic devices require careful management. Patients with pacemakers who subsequently develop ventricular tachycardia requiring an ICD face the decision of device upgrade versus addition of a subcutaneous ICD (S-ICD). Pacemaker-dependent patients are generally not candidates for S-ICD (which cannot provide anti-bradycardia pacing). Electromagnetic interference from other devices (neurostimulators, cochlear implants, bone growth stimulators) may affect pacemaker sensing and require specific programming adjustments or shielded device placement.',
      keyTerms: [
        { term: 'Leadless pacemaker', definition: 'A self-contained miniaturized pacing device implanted directly in the heart via catheter, eliminating the need for transvenous leads and a subcutaneous pulse generator pocket' },
        { term: 'CSP-CRT', definition: 'Conduction system pacing for cardiac resynchronization therapy; using His-bundle or left bundle branch area pacing to achieve ventricular synchrony as an alternative to conventional biventricular pacing' },
        { term: 'Managed Ventricular Pacing (MVP)', definition: 'An adaptive pacing algorithm that operates primarily in AAI mode and automatically switches to DDD when AV block is detected, minimizing unnecessary ventricular pacing' },
        { term: 'Closed-loop stimulation', definition: 'A rate-adaptive algorithm using right ventricular impedance dynamics to modulate pacing rate based on autonomic nervous system activity and hemodynamic changes' },
        { term: 'Epicardial pacing', definition: 'Pacemaker lead placement on the outer surface of the heart via thoracotomy, used in pediatric patients too small for transvenous leads and in congenital heart disease with altered venous anatomy' },
        { term: 'Subcutaneous ICD', definition: 'An entirely extravascular defibrillator system that provides shock therapy without transvenous leads, avoiding intravascular lead-related complications' }
      ],
      clinicalNotes: 'Leadless pacemakers are particularly beneficial for patients with limited venous access, history of device infection requiring extraction, hemodialysis patients (where maintaining venous access is critical), and those at high risk for pocket complications. The Micra AV algorithm requires regular sinus rhythm for AV synchrony; it does not function as a true dual-chamber device in patients with atrial fibrillation. For CSP-CRT, ensure the paced QRS demonstrates correction of the LBBB pattern (qR in V1, absence of notching in lateral leads) to confirm true conduction system capture. Pediatric pacing should be managed at specialized centers with expertise in both congenital heart disease and device management.'
    },
    5: {
      level: 5,
      summary: 'Frontier pacemaker technologies include biological pacing through gene and cell therapy, fully leadless dual-chamber systems, energy harvesting for batteryless devices, optogenetic pacing, and AI-driven autonomous programming optimization.',
      explanation: 'The frontier of cardiac pacing extends beyond conventional electronic devices into biological approaches, novel energy sources, and autonomous computational systems that may fundamentally transform the treatment of bradyarrhythmias.\n\nBiological pacing aims to create a biological substitute for electronic pacemakers by engineering cells that generate spontaneous electrical activity. Approaches include: (1) Gene therapy using viral vectors (adenovirus, lentivirus) to deliver pacemaker genes (HCN2, HCN4, TBX18) to ventricular cardiomyocytes, converting them into pacemaker cells. The TBX18 transcription factor has been shown to reprogram ventricular cardiomyocytes into sinoatrial node-like cells in large animal models, creating a biological pacemaker that responds to autonomic modulation. (2) Cell therapy using induced pluripotent stem cell-derived sinoatrial node cells or embryonic stem cell-derived pacemaker cells transplanted into the myocardium. (3) Somatic cell reprogramming to directly convert fibroblasts into pacemaker cells in situ. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has funded clinical translation research, though human trials remain in early stages. Biological pacing would offer key advantages including autonomic responsiveness, growth potential in pediatric patients, and elimination of hardware-related complications.\n\nFully leadless dual-chamber pacing systems are under active development. The Abbott AZIA system uses two separate leadless capsules (one atrial, one ventricular) that communicate wirelessly to provide true AV synchronous pacing. The Medtronic leadless pacing system with inter-device communication is also in development. Challenges include reliable atrial fixation (the thin-walled atrium increases perforation risk), inter-device communication latency, and increased power consumption from wireless communication reducing battery longevity.\n\nEnergy harvesting technologies aim to create batteryless pacemakers powered by the body\'s own energy. Approaches include: (1) Piezoelectric energy harvesting using flexible nanogenerators attached to the heart that convert mechanical cardiac motion into electrical energy. Demonstrations in animal models have generated sufficient power (several microwatts) to drive a miniaturized pacemaker circuit. (2) Thermoelectric generators using the temperature gradient between the body core and skin surface. (3) Biofuel cells that convert glucose in blood to electricity through enzymatic reactions. (4) Wireless transcutaneous energy transfer using ultrasound or electromagnetic induction. Self-powered pacemakers would eliminate battery depletion as a cause for device replacement and could dramatically reduce the lifetime cost and procedural burden of cardiac pacing.\n\nOptogenetic pacing represents a revolutionary approach where light-sensitive ion channels (channelrhodopsins) are genetically expressed in cardiomyocytes, allowing pacing with light pulses delivered via fiber optic leads or implanted micro-LEDs. Optogenetic pacing has been demonstrated in rodent and zebrafish hearts, with advantages including precise spatial control of activation patterns, potential for painless defibrillation (by activating large regions simultaneously), and elimination of electrode-tissue interface degradation. Translation to clinical use requires solutions for gene delivery, chronic light source implantation, and energy efficiency.\n\nAI-driven autonomous pacemaker programming uses machine learning algorithms to continuously optimize device parameters based on patient activity, hemodynamic data, and arrhythmia patterns. Current adaptive algorithms follow pre-programmed rules, but AI systems could learn individual patient physiology and automatically adjust rate response curves, AV delay, interventricular delay (in CRT), and pacing mode based on real-time data. Integration with wearable sensors (accelerometers, ECG patches, blood pressure monitors) and electronic health records could enable closed-loop optimization without clinic visits. Natural language processing of remote monitoring data could automatically generate clinical alerts for lead dysfunction, battery depletion, and arrhythmia detection, reducing the burden on device clinic staff.\n\nNano-scale pacing technology explores the use of injectable conductive nanomaterials (carbon nanotubes, graphene, gold nanowires) to enhance cardiac conduction across regions of fibrosis or scar, potentially restoring native conduction patterns without traditional lead-based pacing. In animal models, injection of carbon nanotube-polymer composites into the AV junction has restored conduction in models of complete heart block. This approach could provide a minimally invasive alternative to conventional pacing for specific conduction disorders.',
      keyTerms: [
        { term: 'Biological pacing', definition: 'Creation of a biological substitute for electronic pacemakers through gene therapy (HCN channels, TBX18) or cell therapy to generate spontaneous cardiac electrical activity in non-pacemaker cells' },
        { term: 'TBX18 gene therapy', definition: 'Delivery of the TBX18 transcription factor to reprogram ventricular cardiomyocytes into sinoatrial node-like pacemaker cells, creating a biological pacemaker with autonomic responsiveness' },
        { term: 'Piezoelectric energy harvesting', definition: 'Conversion of mechanical cardiac motion into electrical energy using flexible nanogenerators, potentially enabling batteryless self-powered pacemakers' },
        { term: 'Optogenetic pacing', definition: 'Cardiac stimulation using light pulses to activate genetically expressed light-sensitive ion channels (channelrhodopsins) in cardiomyocytes' },
        { term: 'AI-driven autonomous programming', definition: 'Machine learning algorithms that continuously optimize pacemaker parameters based on individual patient physiology, activity patterns, and hemodynamic feedback' },
        { term: 'Conductive nanomaterials', definition: 'Injectable nano-scale materials (carbon nanotubes, graphene) that can enhance cardiac electrical conduction across fibrotic tissue, potentially restoring native conduction without leads' }
      ],
      clinicalNotes: 'Biological pacing and optogenetic approaches remain in preclinical development and are not available for clinical use. Patients inquiring about these technologies should be informed that conventional electronic pacing remains highly effective and reliable. Energy harvesting technologies have demonstrated proof-of-concept but require significant engineering advances before clinical implementation. AI-driven programming optimization is the most near-term frontier technology and may be incorporated into commercial devices within the next decade. For now, regular device follow-up with expert programming remains the standard of care, with remote monitoring serving as the most impactful recent advance in pacemaker management.'
    }
  },
  media: [],
  citations: [
    { id: 'pm-c1', source: 'Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay. Circulation. 2019;140(13):e506-e573.', url: 'https://doi.org/10.1161/CIR.0000000000000628' },
    { id: 'pm-c2', source: 'Vijayaraman P, Chung MK, Dandamudi G, et al. His Bundle Pacing. J Am Coll Cardiol. 2018;72(8):927-947.', url: 'https://doi.org/10.1016/j.jacc.2018.06.017' },
    { id: 'pm-c3', source: 'El-Chami MF, Al-Samadi F, Clementy N, et al. Updated Performance of the Micra Transcatheter Pacemaker in the Real-World Setting. Heart Rhythm. 2018;15(12):1800-1806.', url: 'https://doi.org/10.1016/j.hrthm.2018.08.006' }
  ],
  crossReferences: [
    { contentId: 'cardiaccath', relationship: 'related', description: 'Vascular access techniques used in catheterization are shared with pacemaker implantation procedures' },
    { contentId: 'cardiomyopathy', relationship: 'related', description: 'CRT pacemakers are indicated for heart failure associated with certain cardiomyopathies' },
    { contentId: 'echo', relationship: 'related', description: 'Echocardiography guides CRT optimization and monitors for pacing-induced cardiomyopathy' }
  ],
  tags: {
    defined: ['pacemaker', 'cardiac-pacing', 'bradycardia', 'CRT', 'conduction-system', 'device-therapy', 'electrophysiology'],
    generated: ['leadless-pacing', 'His-bundle', 'LBBAP', 'AV-block', 'sinus-node-dysfunction', 'remote-monitoring']
  },
  createdAt: '2025-01-25',
  updatedAt: '2025-01-25',
  version: 2,
  status: 'published'
};
